Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 84

1.

Expression of the tumor suppressor genes NF2, 4.1B, and TSLC1 in canine meningiomas.

Dickinson PJ, Surace EI, Cambell M, Higgins RJ, Leutenegger CM, Bollen AW, LeCouteur RA, Gutmann DH.

Vet Pathol. 2009 Sep;46(5):884-92. doi: 10.1354/vp.08-VP-0251-D-FL. Epub 2009 May 9.

PMID:
19429976
2.

Calpain-dependent proteolysis of NF2 protein: involvement in schwannomas and meningiomas.

Kimura Y, Saya H, Nakao M.

Neuropathology. 2000 Sep;20(3):153-60. Review.

PMID:
11132929
3.

NF2: the wizardry of merlin.

Xiao GH, Chernoff J, Testa JR.

Genes Chromosomes Cancer. 2003 Dec;38(4):389-99. Review.

PMID:
14566860
4.

Molecular genetics of meningiomas.

Ragel BT, Jensen RL.

Neurosurg Focus. 2005 Nov 15;19(5):E9. Review.

PMID:
16398473
5.

Merlin expression in secretory meningiomas: evidence of an NF2-independent pathogenesis? Immunohistochemical study.

Buccoliero AM, Gheri CF, Castiglione F, Ammannati F, Gallina P, Taddei A, Garbini F, Rossi Degl'Innocenti D, Arganini L, Di Lorenzo N, Mennonna P, Taddei GL.

Appl Immunohistochem Mol Morphol. 2007 Sep;15(3):353-7. Review.

PMID:
17721284
6.

Neurofibromatosis 2.

Baser ME, R Evans DG, Gutmann DH.

Curr Opin Neurol. 2003 Feb;16(1):27-33. Review.

PMID:
12544854
7.

[Neurofibromatosis type 2 (NF2)].

Araki N, Takeshima H, Saya H.

Gan To Kagaku Ryoho. 1997 Sep;24(11):1427-31. Review. Japanese.

PMID:
9309136
8.

Meningioma: an update.

Lusis E, Gutmann DH.

Curr Opin Neurol. 2004 Dec;17(6):687-92. Review.

PMID:
15542977
9.
10.

Neuropathology and molecular genetics of neurofibromatosis 2 and related tumors.

Louis DN, Ramesh V, Gusella JF.

Brain Pathol. 1995 Apr;5(2):163-72. Review.

PMID:
7670657
11.

[The molecular genetics of meningiomas and genotypic/phenotypic correlations].

Dezamis E, Sanson M.

Rev Neurol (Paris). 2003 Sep;159(8-9):727-38. Review. French.

PMID:
13679715
12.

The genetic and molecular pathogenesis of NF1 and NF2.

Yohay KH.

Semin Pediatr Neurol. 2006 Mar;13(1):21-6. Review.

PMID:
16818172
13.

Molecular genetics of meningiomas: from basic research to potential clinical applications.

Simon M, Boström JP, Hartmann C.

Neurosurgery. 2007 May;60(5):787-98; discussion 787-98. Review.

PMID:
17460514
14.
15.

Meningioangiomatosis is associated with neurofibromatosis 2 but not with somatic alterations of the NF2 gene.

Stemmer-Rachamimov AO, Horgan MA, Taratuto AL, Munoz DG, Smith TW, Frosch MP, Louis DN.

J Neuropathol Exp Neurol. 1997 May;56(5):485-9. Review.

PMID:
9143261
16.

Genetic landscape of meningioma.

Yuzawa S, Nishihara H, Tanaka S.

Brain Tumor Pathol. 2016 Oct;33(4):237-247. Epub 2016 Sep 13. Review.

PMID:
27624470
17.

Membrane organization and tumorigenesis--the NF2 tumor suppressor, Merlin.

McClatchey AI, Giovannini M.

Genes Dev. 2005 Oct 1;19(19):2265-77. Review.

18.

The tumour suppressor protein NF2/merlin: the puzzle continues.

Hovens CM, Kaye AH.

J Clin Neurosci. 2001 Jan;8(1):4-7. Review.

PMID:
11148074
19.

Protein 4.1 tumor suppressors: getting a FERM grip on growth regulation.

Sun CX, Robb VA, Gutmann DH.

J Cell Sci. 2002 Nov 1;115(Pt 21):3991-4000. Review.

20.

Tumorigenesis in neurofibromatosis: new insights and potential therapies.

Reed N, Gutmann DH.

Trends Mol Med. 2001 Apr;7(4):157-62. Review.

PMID:
11286939

Supplemental Content

Support Center